Cabaletta Bio (CABA) News Today $1.54 -0.07 (-4.35%) Closing price 04:00 PM EasternExtended Trading$1.57 +0.03 (+1.95%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share News and Trends Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest Cabaletta Bio Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2026 September 2026 August 2026 July 2026 June 2026 May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 Time Period More filters Fewer filters Done Cabaletta Bio (NASDAQ:CABA) Stock Rating Cut to "Strong Sell" at Wall Street ZenOctober 17, 2026 | americanbankingnews.comCabaletta Bio (NASDAQ:CABA) Stock Gets Downgrade from Wall Street ZenOctober 17, 2026 | marketbeat.comCabaletta Bio: 40% Sell-Off Creates An Opportunity Despite Cash ConcernsOctober 13, 2026 | seekingalpha.comCabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 5, 2026 | globenewswire.comCabaletta Bio, Inc. (NASDAQ:CABA) Stock Now Rated "Moderate Buy" by Sell-Side BrokeragesOctober 5, 2026 | marketbeat.comCabaletta Bio (NASDAQ:CABA) Upgraded at Wall Street ZenSeptember 26, 2026 | marketbeat.comCabaletta Bio, Inc. (CABA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeptember 14, 2026 | seekingalpha.comCabaletta Bio to Participate in Upcoming Investor ConferencesSeptember 1, 2026 | globenewswire.comCabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business UpdateAugust 13, 2026 | globenewswire.comCabaletta Bio: The Market Sold The EULAR News, I'm BuyingJune 26, 2026 | seekingalpha.comCabaletta Bio Hits Reset on RESET-MS Trial, Narrowing Near-Term Upside in Multiple SclerosisJune 25, 2026 | tipranks.comHow Cabaletta Bio (CABA) Is Turning Rese-cel Enrollment and New Financing Into a Clearer Autoimmune Cell Therapy SetupJune 17, 2026 | insidermonkey.comCabaletta Bio Shareholders Approve Share Increase and DirectorsJune 11, 2026 | tipranks.comCabaletta Bio, Inc. (CABA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptJune 8, 2026 | seekingalpha.comCabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress - The ...June 8, 2026 | theglobeandmail.comAnalysts Offer Insights on Healthcare Companies: Cabaletta Bio (CABA) and Tenaya Therapeutics (TNYA)June 8, 2026 | theglobeandmail.comCabaletta Bio Inc. (CABA) A Top Penny Stock Eyeing Rese-Cel Commercial Launch for Autoimmune DiseasesJune 7, 2026 | finance.yahoo.comInvestors’ Stock Portfolio: Top 5 Penny Stocks To BuyJune 5, 2026 | insidermonkey.comCabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 CongressJune 3, 2026 | globenewswire.comPemphigus Vulgaris Market Analysis Report 2026-2036, Profiles of F. Hoffmann La Roche, Argenx, Sanofi, Syntimmune, Allmiral, Cabaletta Bio, and NovartisMay 21, 2026 | finance.yahoo.comCabaletta Bio Inc Ordinary Shares CABAMay 17, 2026 | morningstar.comMCabaletta Bio Reports First Quarter 2026 Financial Results and Provides Business UpdateMay 14, 2026 | globenewswire.comCabaletta Bio Presents Preconditioning-free Clinical Data and Automated Manufacturing Translational Data for Rese-cel at ASGCT 2026 Annual MeetingMay 14, 2026 | globenewswire.comCabaletta Bio Shares Rise After $150M Underwritten Offering PricesMay 5, 2026 | marketwatch.comCABA stock on track for best day in 6 months after positive early results from cell therapy trialMay 5, 2026 | msn.comCabaletta Bio Announces Pricing of $150 Million Underwritten OfferingMay 4, 2026 | globenewswire.comCellares and Cabaletta Bio Sign 10-Year Commercial Supply Agreement to Scale Rese-celApril 28, 2026 | businesswire.comCabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-celApril 28, 2026 | globenewswire.comCabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual ...April 28, 2026 | markets.businessinsider.comCabaletta Bio, Inc. to Present New Data on Rese-cel at ASGCT 2026 Annual MeetingApril 27, 2026 | quiverquant.comQCabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual MeetingApril 27, 2026 | globenewswire.comAAN 2026: Phase I/II success for rese-cel in gMG signals potential amid competitionApril 22, 2026 | yahoo.comH.C. Wainwright Remains a Buy on Cabaletta Bio (CABA)April 21, 2026 | theglobeandmail.comFirst Patients Dosed with Cabaletta Bio’s Rese-cel Manufactured on Cellares' Automated Cell Shuttle™ PlatformApril 15, 2026 | finance.yahoo.comFirst Patients Dosed with Cabaletta Bio's Rese-cel Manufactured on Cellares' Automated Cell Shuttle(TM) PlatformApril 15, 2026 | marketwatch.comFirst Patients Dosed with Cabaletta Bio's Rese-cel Manufactured on Cellares' Automated Cell Shuttleâ„¢ PlatformApril 14, 2026 | businesswire.comCabaletta reports results, advances Rese-Cel autoimmune programApril 5, 2026 | msn.comThis Biotech Stock Could Deliver 350% Returns in 12 MonthsMarch 27, 2026 | finance.yahoo.comAnalysts Are Bullish on Top Healthcare Stocks: Cabaletta Bio (CABA), Insmed (INSM)March 25, 2026 | theglobeandmail.comAnalysts Offer Insights on Healthcare Companies: Cabaletta Bio (CABA) and Pyxis Oncology (PYXS)March 24, 2026 | theglobeandmail.comCabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdateMarch 23, 2026 | globenewswire.comCabaletta Bio to Participate in the TD Cowen 46th Annual Health Care ConferenceFebruary 24, 2026 | globenewswire.comAnalysts Offer Insights on Healthcare Companies: Cabaletta Bio (CABA) and Ocular Therapeutix (OCUL)February 11, 2026 | theglobeandmail.comCabaletta Bio takes spotlight at Guggenheim Summit as autoimmune bet advancesFebruary 9, 2026 | msn.comCabaletta Bio to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026February 5, 2026 | quiverquant.comQCabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026February 5, 2026 | globenewswire.comCabaletta Bio: Do You Buy With The Insiders?January 27, 2026 | seekingalpha.comAssessing Cabaletta Bio (CABA) Valuation After Insider Buying And FDA Clearance For Automated CAR T ManufacturingJanuary 27, 2026 | finance.yahoo.comWhy Cabaletta Bio (CABA) Is Up 41.3% After FDA Clears Automated CAR T Manufacturing PlatformsJanuary 23, 2026 | finance.yahoo.comMichael Gerard Purchases 6,600 Shares of Cabaletta Bio (NASDAQ:CABA) StockJanuary 22, 2026 | insidertrades.com Cabaletta Bio Media Mentions By Week Cabaletta Bio Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CABA News Sentiment▼0.570.47▲Average Healthcare News Sentiment Cabaletta Bio News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CABA Articles This Week▼23▲CABA Articles Average Week Cabaletta Bio Trends on MarketBeatThis week vs. last weekNew Followers1Searches5+150%Page Views2,548-15% Get Cabaletta Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for CABA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies DMRA News Today REPL News Today ORIC News Today NBTX News Today TYRA News Today VOR News Today BCAX News Today TRAX News Today JANX News Today MNKD News Today News and Trends Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Cabaletta Bio dated 10/17/2026. From Our PartnersTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billi...Banyan Hill Publishing | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cabaletta Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cabaletta Bio With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
